Improving treatments for retinal diseases requires clinical research

to test new drugs and techniques. These clinicial trials are typically

run in select centers throughout the US and the rest of the world.

The doctors at Vitreoretinal Associates have been involved in

almost every retina related clinical trial run over the last 10 years.

Some of these include the pivotal trials for Lucentis, Verteporfin

based Photodynamic Therapy, and Macugen. These drugs are

treating Age Related Macular Degeneration, Diabetic Retinopathy,

Branch and Central Retinal Vein Occlusions, & Chroroidal

Neovascularization from Myopia and Histoplasmosis Syndrome.

                 Click on the links below to learn more!